EMTRIVA caps 200 mg bte 30 pce
7680568800033
CH-56880
J05AF09
08.03.0.
1 / 3
google
Details
- Product number
- 5688001
- CPT
- -
- Packaging group
- 30
- Unit
- Kapsel(n)
- Composition
- emtricitabinum 200 mg, cellulosum microcristallinum, crospovidonum, povidonum, magnesii stearas, Kapselhülle: gelatina, E 171, E 132, pro capsula.
Articles (1)
Emtriva, Kapseln
Kapseln
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
200.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | FIMDK |
Reimbursement information
Public price
CHF 238.15
Specialties list
Yes
Generic
No
SL addition date:
01/12/2004
Authorization holder
Gilead Sciences Switzerland Sàrl
6300 Zug
Authorization information
- Swissmedic authorization number
- 56880
- Drug name
- Emtriva, Kapseln
- Galenic form
- KAPS
- ATC Code
- J05AF09
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 25/10/2004
- Authorization expiration date
- 31/12/9999
- IT number
- 08.03.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- EMTRIVA caps 200 mg bte 30 pce
- Description (DE)
- EMTRIVA Kaps 200 mg Ds 30 Stk
- Market launch
- 25/10/2004
- Narcotic (BTM)
- No